Lymphoma (includes NHL, HL, CNS Lymphoma)
(PharmaTimes [UK]) Feb 23, 2017 - Mundipharma is gearing up to launch biosimilar Truxima in seven European markets for the treatment of certain cancers and inflammatory conditions, after Celltrion bagged a regulatory approval for the drug.
(labiotech.eu) Dec 6, 2016 - From leukemia to multiple myeloma, biotech is working hard to cure blood cancer. This year’s edition of the American Society of Hematology (ASH) annual meeting features immuno-oncology therapies developed by the best European biotechs, with Novartis taking the lead in the CAR-T field.
There are no Lymphoma (includes NHL, HL, CNS Lymphoma) OBR Green articles.